TP53 and breast cancer: In addition, the triple-negative human breast cancer cells, MDA-MB231 and MDA-MB468, are characterized by a more malignant phenotype [16,17] because they constitutively express mutations of the tumor protein p53, whereas MCF-7 cells have the wild-type p53.